TW201402016A - 水性液體飲料 - Google Patents
水性液體飲料 Download PDFInfo
- Publication number
- TW201402016A TW201402016A TW102112176A TW102112176A TW201402016A TW 201402016 A TW201402016 A TW 201402016A TW 102112176 A TW102112176 A TW 102112176A TW 102112176 A TW102112176 A TW 102112176A TW 201402016 A TW201402016 A TW 201402016A
- Authority
- TW
- Taiwan
- Prior art keywords
- aqueous liquid
- liquid beverage
- mass
- dextrin
- examples
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 31
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 239000004375 Dextrin Substances 0.000 claims abstract description 16
- 229920001353 Dextrin Polymers 0.000 claims abstract description 16
- 235000019425 dextrin Nutrition 0.000 claims abstract description 16
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 8
- 239000000216 gellan gum Substances 0.000 claims abstract description 7
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 6
- 239000004166 Lanolin Substances 0.000 claims description 6
- 229940039717 lanolin Drugs 0.000 claims description 6
- 235000019388 lanolin Nutrition 0.000 claims description 6
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 125000005341 metaphosphate group Chemical group 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 21
- 239000000499 gel Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 6
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000019983 sodium metaphosphate Nutrition 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 235000001727 glucose Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 241000233855 Orchidaceae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 235000001916 dieting Nutrition 0.000 description 2
- 230000037228 dieting effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000790234 Sphingomonas elodea Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical group CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
本發明係提供一種水性液體飲料，其特徵為調配有結蘭膠、糊精、鈣鹽，及偏磷酸或其鹽。
Description
本發明係關於水性之液體飲料，為可利用於醫藥品、準醫藥品及食品等領域。
肥胖係會導致引發代謝症候群之嚴重的社會問題。作為預防肥胖的有效手段，可舉例限制食物攝取量之節食方式，但是實際情況卻因為由此而生的空腹感使得此法不能長期維持。因此，為了消解空腹感，香料或香料化合物作為主成分之空腹感緩和劑(參照專利文獻1)、榖片食品(參照專利文獻2)、可食用磷蛋白及金屬碳酸鹽(參照專利文獻3)等被提供。
作為改善此種空腹感的方法之一，已報導使用寒天，提升於胃液中浸泡一陣子後之寒天的凝膠強度之方法(參照專利文獻4)。然而，堅硬的凝膠需咀嚼後方可吞嚥，以至於此法不可謂之具有高實用性。又，雖已報導有使用含有膠化劑之胃內筏組成物之方法(參照專利文獻5)，但此種凝膠的強度太低，並不足以長時間抑制空腹感。
[專利文獻1]日本特開2008-7427號公報
[專利文獻2]日本特開2007-53929號公報
[專利文獻3]日本特開2010-94085號公報
[專利文獻4]日本特開2008-110923號公報
[專利文獻5]日本特表2009-530254號公報
本發明的目的為提供一種水性液體飲料，其係具有飲用前雖為普通的水性液體飲料，飲用後由於胃中的胃酸而pH值下降，使得鈣無法螯合而凝膠化，滯留於胃中且產生持久飽腹感之性質。
本發明者為了解決上述課題而努力檢討的結果，發現將調配有結蘭膠、糊精、鈣鹽、偏磷酸或其鹽之水性液體飲料，與人工胃液(日局第1液)產生反應而凝膠化，可得到高強度的凝膠。
根據此知識所得到本發明之態樣如下：
(1)一種水性液體飲料，其特徵為調配有結蘭膠、糊精、鈣鹽，及偏磷酸或其鹽。
(2)如前述(1)之水性液體飲料，其中，相對於結蘭膠1質量份，糊精的調配量為4質量份以上。
(3)如前述(1)或(2)之水性液體飲料，其中，結蘭膠為脫醯型結蘭膠。
(4)如前述(1)~(3)中任一項之水性液體飲料，其中，pH值為4.3~7.0。
依據本發明，能提供一種水性液體飲料，其係與胃酸反應而凝膠化，且由於凝膠強度高，使得消解空腹感的狀態能夠長時間地維持。
「結蘭膠」是微生物(Sphingomonas elodea)於菌體外產生之多醣類，已作為增黏安定劑而廣泛使用。結蘭膠作為直鏈狀雜多醣類，是由葡萄糖、葡萄糖醛酸、葡萄糖、鼠李糖等4糖之重複單位所構成，並具有由葡萄糖醛酸而來的羧基。對結蘭膠來說，根據存在於1-3鍵結之葡萄糖中乙醯基與甘油基的有無，可分為脫醯型結蘭膠與天然結蘭膠(native gellan gum)兩種。本發明中任一結蘭膠均可利用。在本發明中，雖然使用任一種結蘭膠都好，但就凝膠強度之點來看脫醯型結蘭膠較佳。
結蘭膠的調配量為水性液體飲料中0.001~1質量%，從服用性或胃中的凝膠強度的點來看，0.01~0.5質
量%更佳。
「糊精」是將澱粉以酸和酵素水解來製造，由數個葡萄糖結合而成者。在本發明中，通常之糊精以外也可以使用難消化性糊精。難消化性糊精是不會被人類消化酵素水解之難消化性、難吸收性的低卡路里水溶性食物纖維。
相對於1質量份的結蘭膠，糊精的調配量為4~3000質量份，4~1000質量份較佳。
「鈣鹽」可舉例如氯化鈣、乳酸鈣、葡萄糖酸鈣、磷酸鈣。
相對於1質量份的結蘭膠，鈣鹽的調配量係鈣為0.001~10質量份，0.01~1質量份較佳。
「偏磷酸鹽」可舉例如偏磷酸鈉、偏磷酸鉀、偏磷酸鈣，偏磷酸或其鹽類可調配1種或2種以上。
相對於1質量份的結蘭膠，偏磷酸或其鹽類的調配量係作為偏磷酸為0.01~100質量份，0.1~30質量份較佳。
以這些調配比例，能提供一種水性液體飲料，其係與胃酸反應而凝膠化，且由於凝膠強度高，使得消解空腹感的狀態能夠長時間地維持。
本發明的水性液體飲料之pH值，從結蘭膠在pH值未滿4.3時會凝膠化來看，以4.3~7.0較佳，就水性液體飲料製造的容易度的點來看，4.4~7.0更佳。
為了確保本發明的水性液體飲料之pH值在上
述範圍內，如有必要可調配有機酸等之pH值調整劑。
又，在不減損本發明效果之範圍內可適宜地調配維他命類、其他礦物質類、胺基酸及其鹽類、生藥、生藥萃取物、咖啡因、蜂王漿等作為其他成分。進一步如有必要，在不減損本發明效果之範圍內可適宜地調配抗氧化劑、著色劑、香料、調味劑、保存劑、甜味料等之添加物。
本發明之水性液體飲料可用常法調製，其方法並沒有特別限定。例如，將各成分秤量後溶解於適量的精製水後，調整pH值，再來加入精製水調整容量，如有必要可以藉由施行濾過、殺菌處理來調製。
本發明之水性液體飲料可提供作為清涼飲料水、機能性飲料之外、保健飲料、糖漿等醫藥品及準醫藥品、茶飲料、運動飲料等食品領域中各種飲料。
以下表示各實施例、比較例及試驗例，更詳細地說明本發明。
於精製水中，添加氯化鈣及作為金屬離子螯合劑之偏磷酸鈉(實施例1~6、比較例6~12)，進而，添加並溶解檸檬酸鈉(比較例1)、L-酒石酸(比較例2)、己二酸(比較例3)、植酸(比較例4)、葡萄糖酸(比較例5)，再以鹽酸‧氫
氧化鈉調整至pH 4.0。將該溶液加熱至80℃，使作為膠化劑的脫醯型結蘭膠(比較例1~6、實施例1~6)、低甲氧基果膠(比較例10~12)、海藻酸鈉(比較例7~9)溶解，該溶液中進一步加入糊精(實施例1~6、比較例8、9、11、12)，及精製水使全量成為100mL(實施例3~6之樣本進一步加入鹽酸‧氫氧化鈉將pH值調整至4.4或7.0)。各試驗液填充至玻璃瓶後殺菌，得到了表1~3所示之實施例1~6以及比較例1~12的飲料。
對表1~3記載的樣本之調製後立即的狀態以肉眼觀察進行評估，此結果表示於表4~6。
在調配檸檬酸鈉、L-酒石酸、己二酸、植酸或葡萄糖酸作為金屬離子螯合劑的情況中，如同比較例1~5所示於調製後立即凝膠化，並沒有得到飲用前為水性液體飲料之相當於本發明的樣本。
另一方面，如同比較例6及實施例1~6，在調配偏磷酸鈉作為金屬離子螯合劑的情況中，得到了飲用前為水性液體飲料之相當於本發明的樣本。
凝膠強度(斷裂強度)以下述之方法測定。
於50mL燒杯中加入12.5mL之實施例1及2
以及比較例6~12中所調配的飲料樣本，將12.5mL的日局1液(日本藥局方崩壞試驗法第1液)沿著壁面靜靜地滴下，日局1液是相當於胃液的酸性液體(pH值1.2)。在室溫放置一小時後，以黏彈性測定裝置測定凝膠強度(斷裂強度)。
使用機器：FUDOH流變儀(RHEOTECH製 型式：RT-2100NJ-CW)
使用接頭：黏彈性粗圓棒 20mm
試驗模式：斷裂試驗
測定範圍：20N
紀錄表速度：1cm/min
對於表2及表3所記載的樣本進行3次凝膠強度測定的結果平均值，表示於表7及表8中。
如同實施例1及2同時調配糊精和偏磷酸鈉之方式與比較例6相比，凝膠強度(斷裂強度)有顯著地增加。如同比較例7~12，使用海藻酸或低甲氧基果膠而非結蘭膠作為膠化劑的情況下，即使同時調配糊精和偏磷酸鈉也不認為凝膠強度有上升。
如同實施例3及4調配有糊精且pH值成為4.4~7.0之方式與比較例1相比，凝膠強度(斷裂強度)有顯著地增加。
如同實施例5及6，相對於結蘭膠1質量份，調配4質量份以上之糊精之方式與比較例1相比，凝膠強度(斷裂強度)有顯著地增加。
根據本發明，能提供一種水性液體飲料，其係與胃酸反應而凝膠化，且由於凝膠強度高，使得消解空腹感的狀態能夠長時間地維持。因此，藉由提供本發明作為以預防肥胖之節食為目標的醫藥品、準醫藥品及食品，對於此等產業的發達是被期待的。
Claims (4)
- 一種水性液體飲料，其特徵係調配有結蘭膠、糊精、鈣鹽，及偏磷酸或其鹽。
- 如請求項1之水性液體飲料，其中，相對於結蘭膠1質量份，糊精之調配量係4質量份以上。
- 如請求項1或2之水性液體飲料，其中，結蘭膠係脫醯型結蘭膠。
- 如請求項1~3中任1項之水性液體飲料，其中，pH值係4.3~7.0。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012085094 | 2012-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201402016A true TW201402016A (zh) | 2014-01-16 |
Family
ID=49300561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102112176A TW201402016A (zh) | 2012-04-04 | 2013-04-03 | 水性液體飲料 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2013151080A1 (zh) |
| TW (1) | TW201402016A (zh) |
| WO (1) | WO2013151080A1 (zh) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5528718B2 (ja) * | 2008-03-31 | 2014-06-25 | 株式会社Ａｄｅｋａ | βグルカン組成物を用いた血糖値上昇抑制剤及びインスリン分泌促進剤 |
| JP2011078363A (ja) * | 2009-10-08 | 2011-04-21 | Sanei Gen Ffi Inc | カフェインの苦味抑制方法 |
| JP2011147444A (ja) * | 2009-12-25 | 2011-08-04 | Kaneka Corp | 乳化食品組成物 |
| JP5618605B2 (ja) * | 2010-04-21 | 2014-11-05 | ライオン株式会社 | 衣料用液体漂白剤組成物 |
| WO2011152452A1 (ja) * | 2010-06-02 | 2011-12-08 | ライオン株式会社 | 衣料用液体漂白性組成物 |
-
2013
- 2013-04-03 TW TW102112176A patent/TW201402016A/zh unknown
- 2013-04-03 WO PCT/JP2013/060168 patent/WO2013151080A1/ja active Application Filing
- 2013-04-03 JP JP2014509179A patent/JPWO2013151080A1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013151080A1 (ja) | 2013-10-10 |
| JPWO2013151080A1 (ja) | 2015-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2676058C (en) | Diet product comprising alginate | |
| TWI637694B (zh) | 水性碳酸飲料 | |
| JP2004283073A (ja) | 咀嚼・嚥下困難者用食品ならびに咀嚼・嚥下補助組成物 | |
| Lee et al. | Effect of salivary reaction time on flow properties of commercial food thickeners used for dysphagic patients | |
| JP4044128B1 (ja) | タンパク質含有液状組成物用増粘化剤 | |
| JP6026874B2 (ja) | コラーゲン含有酸性ゲル状飲食品 | |
| TW201402015A (zh) | 水性液體飲料 | |
| JP2010268709A (ja) | 酸性ゲル状食品 | |
| TW201402017A (zh) | 水性液體飲料 | |
| JP2009183212A (ja) | 酸性飲料 | |
| JP4410074B2 (ja) | 酸性ゲル状食品 | |
| TW201402135A (zh) | 水性液體飲料 | |
| TW201402016A (zh) | 水性液體飲料 | |
| CN102144744B (zh) | 一种低硬度营养果冻及其制备方法和应用 | |
| TWI700046B (zh) | 凝膠劑組成物及食品 | |
| JP7154237B2 (ja) | コラーゲンペプチドを含む液状経口用組成物及び液状経口用組成物の酸味を緩和する方法 | |
| JP6425020B2 (ja) | 水性液体飲料 | |
| JP4937202B2 (ja) | 酸性透明ゲル状食品 | |
| JP2011254709A (ja) | 食品品質改良剤 | |
| JP2019136036A (ja) | 液状食品 | |
| JP2015019658A (ja) | 嚥下促進効果を奏するゲル状飲食品 | |
| JP4937227B2 (ja) | 酸性透明ゲル状食品 | |
| JP5193131B2 (ja) | 酸性透明ゲル状食品 | |
| JP2013031404A (ja) | レトルト殺菌処理された高タンパク質ゲル状食品 | |
| JP2019103493A (ja) | 炭酸飲料 |